Older men with low serum IGF‐1 have an increased risk of incident fractures: The MrOS Sweden study

Osteoporosis‐related fractures constitute a major health concern not only in women but also in men. Insulin‐like growth factor 1 (IGF‐1) is a key determinant of bone mass, but the association between serum IGF‐1 and incident fractures in men remains unclear.

[1]  K. Sjögren,et al.  The role of liver-derived insulin-like growth factor-I. , 2009, Endocrine reviews.

[2]  C. Rosen,et al.  Insulin-like growth factor-I and bone: lessons from mice and men , 2009, Pediatric Nephrology.

[3]  I. Hafström,et al.  Impact of low-dose prednisolone on bone synthesis and resorption in early rheumatoid arthritis: experiences from a two-year randomized study , 2008, Arthritis research & therapy.

[4]  S. Giovannini,et al.  Modulation of GH/IGF-1 axis: Potential strategies to counteract sarcopenia in older adults , 2008, Mechanisms of Ageing and Development.

[5]  D. Mellström,et al.  Older Men With Low Serum Estradiol and High Serum SHBG Have an Increased Risk of Fractures , 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[6]  D. Leroith.  Clinical relevance of systemic and local IGF-I: lessons from animal models. , 2008, Pediatric endocrinology reviews : PER.

[7]  G. Mazziotti,et al.  Growth hormone, insulin-like growth factors, and the skeleton. , 2008, Endocrine reviews.

[8]  S. Mohan,et al.  Conditional deletion of insulin-like growth factor-I in collagen type 1alpha2-expressing cells results in postnatal lethality and a dramatic reduction in bone accretion. , 2007, Endocrinology.

[9]  S. Mohan,et al.  Disruption of insulin-like growth factor-I expression in type IIalphaI collagen-expressing cells reduces bone length and width in mice. , 2007, Physiological genomics.

[10]  S. Yano,et al.  Serum insulin-like growth factor-I level is associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes mellitus , 2007, Osteoporosis International.

[11]  J. Bilezikian,et al.  Glucocorticoid-induced osteoporosis: pathophysiology and therapy , 2007, Osteoporosis International.

[12]  O. Johnell,et al.  Free Testosterone is an Independent Predictor of BMD and Prevalent Fractures in Elderly Men: MrOS Sweden , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[13]  J. Schölmerich,et al.  Anti-TNF antibody treatment improves glucocorticoid induced insulin-like growth factor 1 (IGF1) resistance without influencing myoglobin and IGF1 binding proteins 1 and 3 , 2005, Annals of the rheumatic diseases.

[14]  E. Romagnoli,et al.  Effect of estrogen deficiency on IGF-I plasma levels: Relationship with bone mineral density in perimenopausal women , 1993, Calcified Tissue International.

[15]  Jeroen J. Bax,et al.  Homozygous and heterozygous expression of a novel insulin-like growth factor-I mutation. , 2005, The Journal of clinical endocrinology and metabolism.

[16]  A. Hofman,et al.  The Influence of an Insulin‐Like Growth Factor I Gene Promoter Polymorphism on Hip Bone Geometry and the Risk of Nonvertebral Fracture in the Elderly: The Rotterdam Study , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[17]  P. Delmas,et al.  Insulin-Like Growth Factor I Is a Determinant of Hip Bone Mineral Density in Men Less Than 60 years of Age: MINOS Study , 2004, Calcified Tissue International.

[18]  P. Strisciuglio,et al.  A novel mutation in a patient with insulin-like growth factor 1 (IGF1) deficiency , 2003, Journal of medical genetics.

[19]  Jun Ren,et al.  Insulin-like growth factors (IGFs) and IGF-binding proteins in nephrotic syndrome children on glucocorticoid. , 2003, Pharmacological research.

[20]  K. Sjögren,et al.  Effects of Liver‐Derived Insulin‐Like Growth Factor I on Bone Metabolism in Mice , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[21]  D. Leroith,et al.  Circulating levels of IGF-1 directly regulate bone growth and density. , 2002, The Journal of clinical investigation.

[22]  A. Klibanski,et al.  Effects of recombinant human IGF-I and oral contraceptive administration on bone density in anorexia nervosa. , 2002, The Journal of clinical endocrinology and metabolism.

[23]  P. Geusens,et al.  Musculoskeletal effects of the recombinant human IGF-I/IGF binding protein-3 complex in osteoporotic patients with proximal femoral fracture: a double-blind, placebo-controlled pilot study. , 2002, The Journal of clinical endocrinology and metabolism.

[24]  J. de Dios Luna,et al.  The contribution of IGF‐I to skeletal integrity in postmenopausal women , 2001, Clinical endocrinology.

[25]  P. Simpson,et al.  Statistical methods in cancer research , 2001, Journal of surgical oncology.

[26]  C. C. Pillai,et al.  IGFs and IGF-binding proteins in short children with steroid-dependent nephrotic syndrome on chronic glucocorticoids: changes with 1 year exogenous GH. , 2001, European journal of endocrinology.

[27]  S. Ljunghall,et al.  Bone Mineral Density in Femoral Neck is Positively Correlated to Circulating Insulin-Like Growth Factor (IGF)-I and IGF-Binding Protein (IGFBP)-3 in Swedish Men , 2001, Calcified Tissue International.

[28]  P. Delmas,et al.  Low serum IGF-1 and occurrence of osteoporotic fractures in postmenopausal women , 2000, The Lancet.

[29]  O. Johnell,et al.  Long-Term Risk of Osteoporotic Fracture in Malmö , 2000, Osteoporosis International.

[30]  J. Eisman,et al.  Hormonal and biochemical parameters in the determination of osteoporosis in elderly men. , 1999, The Journal of clinical endocrinology and metabolism.

[31]  D. Leroith,et al.  Normal growth and development in the absence of hepatic insulin-like growth factor I. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[32]  K. Sjögren,et al.  Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[33]  J. Eisman,et al.  Mortality after all major types of osteoporotic fracture in men and women: an observational study , 1999, The Lancet.

[34]  D. Kiel,et al.  Association between insulin-like growth factor I and bone mineral density in older women and men: the Framingham Heart Study. , 1998, The Journal of clinical endocrinology and metabolism.

[35]  E. Barrett-Connor,et al.  Gender Differences in Insulin‐like Growth Factor and Bone Mineral Density Association in Old Age: The Rancho Bernardo Study , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[36]  R. Swaminathan,et al.  Insulin-like growth factor-I and bone mineral density. , 1998, Bone.

[37]  R. Stolk,et al.  Gender-specific relationship between serum free and total IGF-I and bone mineral density in elderly men and women. , 1998, European journal of endocrinology.

[38]  C. Ohlsson,et al.  Growth hormone and bone. , 1998, Endocrine reviews.

[39]  K. Chihara,et al.  Serum Levels of Insulin‐like Growth Factor (IGF) I, IGF‐Binding Protein (IGFBP)‐2, and IGFBP‐3 in Osteoporotic Patients with and without Spinal Fractures , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[40]  E. Lesaffre,et al.  Relationship Between Baseline Insulin‐Like Growth Factor‐I (IGF‐I) and Femoral Bone Density in Women Aged Over 70 Years: Potential Implications for the Prevention of Age‐Related Bone Loss , 1996, Journal of the American Geriatrics Society.

[41]  M. Savage,et al.  Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. , 1996, The New England journal of medicine.

[42]  M. Prummel,et al.  The effect of long-term prednisone treatment on growth hormone and insulin-like growth factor-I , 1996 .

[43]  C. Ohlsson,et al.  Cortisol decreases IGF-I mRNA levels in human osteoblast-like cells. , 1996, The Journal of endocrinology.

[44]  S. Ljunghall,et al.  Effects of growth hormone and insulin-like growth factor I in men with idiopathic osteoporosis. , 1996, The Journal of clinical endocrinology and metabolism.

[45]  R. Marcus,et al.  Effects of recombinant insulin‐like growth factor‐I and growth hormone on bone turnover in elderly women , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[46]  D. Rudman,et al.  Relations of endogenous anabolic hormones and physical activity to bone mineral density and lean body mass in elderly men , 1994, Clinical endocrinology.

[47]  N. Breslow,et al.  Statistical methods in cancer research. Volume II--The design and analysis of cohort studies. , 1987, IARC scientific publications.

[48]  D. Krewski,et al.  Statistical Methods in Cancer Research: Volume III: The Design and Analysis of Long-Term Animal Experiments , 1987 .

[49]  R L Hintz,et al.  Insulin-like growth factors I and II: aging and bone density in women. , 1984, The Journal of clinical endocrinology and metabolism.